PSA VELOCITY IN MEN STARTING 5-ALPHA- REDUCTASE INHIBITORS AT THE TIME OF STARTING ACTIVE SURVEILLANCE IS A PREDICTOR OF PATHOLOGICAL PROGRESSION IN LOW-RISK PROSTATE CANCER

被引：0
|
作者：
Timilshina, Narhari
Alibhai, Shabbir
Komisarenko, Maria
Martin, Lisa
Grewal, Ruby
Hamilton, Rob
Kulkarni, Girish
Zlotta, Alexandre
Fleshner, Neil
Finelli, Antonio
机构：
来源：
JOURNAL OF UROLOGY | 2017年 / 197卷 / 04期
关键词：
D O I：
10.1016/j.juro.2017.02.2429
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD55-06
引用
收藏
页码：E1053 / E1053
页数：1
相关论文
共 50 条
  • [21] Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression
    Marc A Dall'Era
    Badrinath R Konety
    Nature Clinical Practice Urology, 2008, 5 : 277 - 283
  • [22] Active surveillance in men with low-risk prostate cancer: current and future challenges
    Han, Christopher Sejong
    Parihar, Jaspreet Singh
    Kim, Isaac Yi
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2013, 1 (01): : 72 - 82
  • [23] Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate Cancer
    Olsson, Henrik
    Nordstrom, Tobias
    Clements, Mark
    Gronberg, Henrik
    Lantz, Anna Wallerstedt
    Eklund, Martin
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (05): : 640 - 647
  • [24] Active surveillance guidance for New Zealand men with low-risk prostate cancer
    Nacey, John
    Delahunt, Brett
    Mark, Stephen
    Matthews, John
    Williams, Andrew
    White, Trish
    Simpson, Andrew
    NEW ZEALAND MEDICAL JOURNAL, 2015, 128 (1420) : 13 - 15
  • [25] Active Surveillance for Black Men with Low-Risk Prostate Cancer in the United States
    Al Awamlh, Bashir Al Hussein
    Hu, Jim C.
    Shoag, Jonathan E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (26): : 2581 - 2582
  • [26] Can PSA doubling time exactly predict the candidates for active surveillance in patients with low-risk prostate cancer?
    Maruyama, Satoru
    Shinohara, Nobuo
    Abe, Takashige
    Sazawa, Ataru
    Nonomura, Katsuya
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [27] Impact of 5-Alpha Reductase Inhibitors on Men Followed by Active Surveillance for Prostate Cancer: A Time-dependent Covariate Reanalysis
    Wong, Lih-Ming
    Fleshner, Neil
    Finelli, Antonio
    EUROPEAN UROLOGY, 2013, 64 (02) : 343 - 343
  • [28] 5-ALPHA REDUCTASE INHIBITORS IN PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER: IMPACT ON DISEASE PROGRESSION AND CURATIVE INTERVENTION
    Abreu, Andre Luis de Castro
    Gill, Inderbir
    Bahn, Duke
    Shoji, Sunao
    Marien, Arnaud
    Cai, Jie
    Chopra, Sameer
    Azhar, Raed
    Wong, Kelvin
    Metcalfe, Charles
    Satkunasivam, Raj
    Ukimura, Osamu
    JOURNAL OF UROLOGY, 2015, 193 (04): : E756 - E756
  • [29] Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria
    Mitsuzuka, Koji
    Narita, Shintaro
    Koie, Takuya
    Kaiho, Yasuhiro
    Tsuchiya, Norihiko
    Yoneyama, Takahiro
    Kakoi, Narihiko
    Kawamura, Sadafumi
    Tochigi, Tatsuo
    Habuchi, Tomonori
    Ohyama, Chikara
    Arai, Yoichi
    BJU INTERNATIONAL, 2013, 111 (06) : 914 - 920
  • [30] HEALTH LITERACY, ANXIETY, AND RISK OF HOSPITALIZATION IN MEN ON ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER
    Rogers, James
    Cullen, Brittany D.
    Epling, Joel
    Sartor, Oliver
    Silberstein, Jonathan
    Feibus, Allison
    Hoerger, Michael
    ANNALS OF BEHAVIORAL MEDICINE, 2018, 52 : S231 - S231
12345